About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Exploring Vancomycin Disposition in Neonates | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 4NCT02096536

Exploring Vancomycin Disposition in Neonates

Vancomycin is already used for decades in neonates. However, there are remaining questions concerning vancomycin disposition in this population. The purpose of this study is first of all to perform a ...

Lead sponsor: Universitaire Ziekenhuizen KU Leuven•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Anne Smits, MD

CONTACT

003216341564 anne.smits@uzleuven.be

Karel Allegaert, MD, PhD

CONTACT

003216343210 karel.allegaert@uzleuven.be

Sponsors

Lead Sponsor

Universitaire Ziekenhuizen KU Leuven

Exploration of vancomycin disposition in neonates: Objective 1: Paired analysis of (total) serum vancomycin concentrations in neonates using the currently available immunoassay (Cobas c702) versus a reference liquid chromatography-tandem mass spectrometry method (LC-MS/MS). Objective 2: The determination of vancomycin protein binding and its covariates in neonates.

Age

0 - 1 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Neonates, admitted to the Neonatal Intensive Care Unit to whom vancomycin is administered for medical reasons, can be included in the study after informed consent of the parents.

Exclusion Criteria

•No vancomycin therapy
•No signed informed consent available

Related studies

Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections

NCT06656104 · Neonatal Infection

Prenatal Antibiotics and Breast Milk / Neonatal IgA

NCT05813184 · Prenatal Exposure Delayed Effects, Antibiotic Prophylaxis, and more

Active Not Recruiting

COPE - COVID-19 in Pregnancy and Early Childhood

NCT04433364 · Sars-CoV2, Covid-19, and more

Maternal- Fetal Infection

NCT03371056 · Neonatal Infection

Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis

NCT01719510 · Neonatal Infections Colonize With Group B Streptococci

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 12, 2024Terms

Trial snapshot

StatusRECRUITING

PhasePHASE4

Enrollment120

Start dateApr 2014

Last updatedJul 12, 2024

Condition

Neonatal Infection

Locations shown

UZ Leuven

Leuven, Vlaams-Brabant

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 12, 2024Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions